1. Home
  2. TLSA vs DMRC Comparison

TLSA vs DMRC Comparison

Compare TLSA & DMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • DMRC
  • Stock Information
  • Founded
  • TLSA 2013
  • DMRC 2008
  • Country
  • TLSA United Kingdom
  • DMRC United States
  • Employees
  • TLSA N/A
  • DMRC N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • DMRC EDP Services
  • Sector
  • TLSA Health Care
  • DMRC Technology
  • Exchange
  • TLSA Nasdaq
  • DMRC Nasdaq
  • Market Cap
  • TLSA 187.0M
  • DMRC 218.5M
  • IPO Year
  • TLSA 2000
  • DMRC N/A
  • Fundamental
  • Price
  • TLSA $1.97
  • DMRC $9.69
  • Analyst Decision
  • TLSA
  • DMRC Strong Buy
  • Analyst Count
  • TLSA 0
  • DMRC 1
  • Target Price
  • TLSA N/A
  • DMRC $30.00
  • AVG Volume (30 Days)
  • TLSA 455.3K
  • DMRC 189.0K
  • Earning Date
  • TLSA 05-06-2025
  • DMRC 11-13-2025
  • Dividend Yield
  • TLSA N/A
  • DMRC N/A
  • EPS Growth
  • TLSA N/A
  • DMRC N/A
  • EPS
  • TLSA N/A
  • DMRC N/A
  • Revenue
  • TLSA N/A
  • DMRC $35,479,000.00
  • Revenue This Year
  • TLSA N/A
  • DMRC N/A
  • Revenue Next Year
  • TLSA N/A
  • DMRC N/A
  • P/E Ratio
  • TLSA N/A
  • DMRC N/A
  • Revenue Growth
  • TLSA N/A
  • DMRC N/A
  • 52 Week Low
  • TLSA $0.63
  • DMRC $7.77
  • 52 Week High
  • TLSA $2.60
  • DMRC $48.32
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 53.23
  • DMRC 48.43
  • Support Level
  • TLSA $1.90
  • DMRC $9.53
  • Resistance Level
  • TLSA $2.18
  • DMRC $10.17
  • Average True Range (ATR)
  • TLSA 0.17
  • DMRC 0.46
  • MACD
  • TLSA 0.02
  • DMRC 0.01
  • Stochastic Oscillator
  • TLSA 46.48
  • DMRC 12.78

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About DMRC Digimarc Corporation

Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.

Share on Social Networks: